Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Co-transporter 2 Inhibitors”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Not applicableStudy completedNCT02636192
What this trial is testing

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 200,000
Post-approval studies (Phase 4)Study completedNCT05735197
What this trial is testing

Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseasesBone Diseases, Metabolic
Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT05914857
What this trial is testing

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Who this might be right for
Prediabetic StateImpaired Fasting GlucoseImpaired Glucose Tolerance
Yangjin 120
Testing effectiveness (Phase 2)WithdrawnNCT04640493
What this trial is testing

SGLT2-Inhibitors for Sleep Apnea in Heart Failure

Who this might be right for
Heart FailureSleep Disordered Breathing
Columbia University
Post-approval studies (Phase 4)Looking for participantsNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Post-approval studies (Phase 4)Study completedNCT05278962
What this trial is testing

HF Patients With LVADs Being Treated With SGLT2i

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of Chicago 32
Post-approval studies (Phase 4)Study completedNCT03959501
What this trial is testing

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Who this might be right for
Type 2 DiabetesKetonemia
The University of Hong Kong 60
Not applicableStudy completedNCT06000722
What this trial is testing

SGLT-i Use in Diabetic Foot Ulcer Disease

Who this might be right for
Diabetic Foot Ulcer
University of Leicester 21
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682350
What this trial is testing

SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

Who this might be right for
Kidney Transplant RecipientSodium Glucose Co-Transporter 2 InhibitorsNon-Diabetic Patients+3 more
Odense University Hospital 184
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Post-approval studies (Phase 4)Looking for participantsNCT06249932
What this trial is testing

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Who this might be right for
Heart Failure with Reduced Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital 95
Not applicableStudy completedNCT03741972
What this trial is testing

Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure

Who this might be right for
Heart Failure
Germans Trias i Pujol Hospital 100
Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Not applicableStudy completedNCT06902493
What this trial is testing

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

Who this might be right for
SepsisSeptic ShockAcute Kidney Injury
University of Jazan 664
Very early researchUnknownNCT04780438
What this trial is testing

Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.

Who this might be right for
Atrial Fibrillation RecurrentPulmonary Venous IsolationCatheter Ablation+1 more
G.Gennimatas General Hospital 350
Next Page